0001490054 false false 0001490054 2023-06-23 2023-06-23

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934

 

Date of Report (Date of earliest event reported): June 23, 2023

 

VERDE BIO HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

 

 

Nevada

 

000-54524

 

30-0678378

(State or Other Jurisdiction
of Incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

 

5750 Genesis Court, Suite 220

Frisco, Texas 75034

(Address of Principal Executive Offices)

 

 

(972) 217-4080

(Registrant’s Telephone Number, Including Area Code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 2.01 Acquisition or Disposition of Assets

On June 27, 2023, Verde Bio Holdings, Inc. (the “Company”) announced that it had closed on a transaction of certain mineral and royalty interests (“Acquisition”) with a private buyer whereby the Company divested 55% of certain mineral and oil and gas royalty interests for $398,750 in cash, (“Purchase Price”). The acquisition closed on June 23, 2023, with the effective date of the acquisitions June 1, 2023.

A form of the Purchase Agreement is filed as Exhibit 10.1to this Current Report on Form 8-K.

 

Item 9.01

 

Financial Statements and Exhibits.

 

Exhibits. The following exhibits are being filed herewith:

 

 Exhibit Number

 

10.1

 

99.1

 

 

 

 

 

 

Description of Exhibits

 

Purchase and Sale Agreement

 

Press Release issued June 27, 2023

 

 

 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 28th day of June, 2023.

 

 

 

 

 

 

VERDE BIO HOLDINGS, INC.

 

 

 

By:  

/s/ Scott A. Cox

 

 

 

Name: 

Scott A. Cox

 

 

 

Title:  

Chief Executive Officer

 

 

  

 

Exhibit Index to Current Report on Form 8-K

 

 Exhibit Number

 

10.1

99.1

 

 

 

 

 

 Description of Exhibits 

 

 Purchase and Sale Agreement  

                            Press Release

 

 

 

 

 

 

Apogee 21 (CE) (USOTC:APHD)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Apogee 21 (CE) Charts.
Apogee 21 (CE) (USOTC:APHD)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Apogee 21 (CE) Charts.